Carolina Andrea Campos

Ms. Carolina Andrea Campos

Farmacia, University of Valparaíso, Valparaíso, Chile

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SASebastián Alfaro
Sebastián Alfaro
VAVania Acuña
Vania Acuña
RCRicardo Ceriani
Ricardo Ceriani
MCMaría Fernanda Cavieres
María Fernanda Cavieres
CWCaroline Weinstein-Oppenheimer
Caroline Weinstein-Oppenheimer
CCCarolina Andrea Campos
Carolina Andrea Campos
Inflammation plays a critical role in the response to and survival from injuries and/or infections. It occurs in two phases: initiation and resolution; however, when these events do not resolve and persist over time, the inflammatory response becomes chronic, prompting diseases that affect several systems and organs, such as the vasculature and the skin. Here, we reviewed inflammation that occurs in selected infectious and sterile pathologies. Thus, the immune processes induced by bacterial sepsis as well as T. cruzi and SARS-CoV-2 infections are shown. In addition, vaccine adjuvants as well as atherosclerosis are revised as examples of sterile-mediated inflammation. An example of the consequences of a lack of inflammation resolution is given through the revision of wound healing and chronic wounds. Then, we revised the resolution of the latter through advanced therapies represented by cell therapy and tissue engineering approaches, showing how they contribute to control chronic inflammation and therefore wound healing. Finally, new pharmacological insights into the management of chronic inflammation addressing the resolution of inflammation based on pro-resolving mediators, such as lipoxin, maresin, and resolvins, examining their biosynthesis, biological properties, and pharmacokinetic and pharmaceuticals limitations, are given. We conclude that resolution pharmacology and advanced therapies are promising tools to restore the inflammation homeostasis.

11 June 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
VTValeska Guevara Torrejón
Valeska Guevara Torrejón
PPPaola Chandía Parra
Paola Chandía Parra
CCCarolina Andrea Campos
Carolina Andrea Campos
WVWaleska Vera
Waleska Vera
The ulvans are sulfated heteropolysaccharides that can stimulate the immune response in vitro. Using a human cell model, this study aimed to characterize and evaluate the immunostimulatory properties of crude ulvans extracted from Ulva spp., collected in Algarrobo, Chile. The crude ulvans, characterized by spectrophotometric methods, are composed of 47.6% total sugars, 14.3% uronic acids, and 8.9% sulfates, with an average molecular weight of 40.000 kDa. The FTIR spectrum showed bands related to uronic acids, rhamnose, and sulfate groups. GCMS analysis confirmed the presence of rhamnose, xylose, glucose, and galactose, with a predominance of the disaccharides U3s and B3s. HL60 cells differentiated into macrophages were cultured with three concentrations of crude ulvans (25, 50, and 100 μg/mL), with cell viability remaining above 90% at the lower concentrations. The crude ulvan activated CD86 co-stimulatory molecules and promoted the release of IL-6, IL-10, IL-4, and nitric oxide cytokines. The results suggest that ulvan is non-toxic and can activate inflammatory pathways, making it a potential candidate for studies as a vaccine adjuvant.

25 June 2019 in Schizophrenia Research and Treatment
Verified
Journal Article
Open access
PDF file
ACAlvaro Cavieres
Alvaro Cavieres
CCCarolina Andrea Campos
Carolina Andrea Campos
YMYanneth Moya-Olave
Yanneth Moya-Olave
RMRocío Maldonado
Rocío Maldonado
RGRené González-Vargas
René González-Vargas
PMPablo R Moya
Pablo R Moya
Alterations in neuroinflammatory processes have been suggested to contribute to the development of Schizophrenia (SZ); one component of the inflammatory system that has been linked to this disorder is interleukin-6 (IL-6). The minor allele of rs2228145, a functional polymorphism in the IL-6 receptor gene, has been associated to elevated IL-6 plasma levels and increased inflammatory activity, making it an interesting candidate to study as a possible factor underlying clinical heterogeneity in SZ. We studied a sample of 100 patients undergoing treatment with clozapine. Their symptoms were quantified by Brief Psychotic Rating Scale; those with the lowest scores (“remitted”) were compared with the highest (“clozapine treatment resistant”). We determined allelic frequencies for rs2228145 and IL-6 plasma levels. Our results do not support a role of IL-6 in response to treatment with clozapine. Further studies accounting for potential confounding factors are necessary.

22 September 2025 in Molecules
Verified
Journal Article
Open access
PDF file
CRCecilia Rubio
Cecilia Rubio
JRJaviera Ramírez
Javiera Ramírez
JRJosé L. Rojas
José L. Rojas
NVNorma A Valencia-Islas
Norma A Valencia-Islas
CCCarolina Andrea Campos
Carolina Andrea Campos
NQNatalia Quiñones
Natalia Quiñones
Exposure to sunlight, whose main component is UV radiation (UVR), leads to various skin damage such as sunburns, premature aging, or more severe issues such as increased symptoms of autoimmune disease and skin cancer. Therefore, there is a growing interest in developing improved photoprotective agents that can protect skin from sunlight incidence and antioxidants that counteract the oxidative stress caused by it. Lichens are a source of such agents since they adapt to extreme environments including those with high UVR by biosynthesizing metabolites with those properties. In this study, brialmontin 2 (1), physciosporin (2), and pseudocyphellarin A (3) were isolated for the first time from the lichen Pseudocyphellaria berberina (G. Forst.) D. J. Galloway & P. James, along with calycin (4) and 22-hydroxystictan-3-one (5). Their structural characterization was carried out by spectroscopy (1H and 13C NMR). Sun protection factor (SPF) along with critical wavelength (λcrit), a UVA/UVB ratio (UVA/UVB-r) of one to five, and acetone extract (AE) were evaluated spectrophotometrically as a measure of their UVB and UVA photoprotective capacities, respectively. Additionally, their antioxidant activity was measured by scavenging DPPH free radicals (RSA). Compounds 2, 4, and AE showed “medium” UVB photoprotective capacities (with SPFs between 15 and 30). Additionally, 4 and AE presented “maximum” UVA photoprotective capacities (λcrit > 370 nm and UVA/UVB-r > 0.8), whereas this activity was “good” for 2 and 3 (λcrit 350 to 370 nm and UVA/UVB-r 0.4 to 0.6), and “moderate” for 1 (λcrit 335 to 350 nm and UVA/UVB-r 0.2 to 0.4). All compounds and AE showed antioxidant activity, standing out were AE and 4 with activity comparable to the controls (ca. 95 and 81 RSA %, respectively, at 1000 ppm). AE and 4 are dual agents with photoprotective (UVB-UVA) and antioxidant capacities that could help prevent skin damage associated with sunlight. In silico assays suggest that 4 spontaneously diffuses into the stratum corneum with limited absorption through the skin. Additionally, 4 lacks potential toxicity to Normal Human Epidermal Keratinocytes (showing viability ca. 70% at 100 ppm); therefore, it is a candidate for the development of sunscreen formulations.

12 June 2024 in Journal of International Crisis and Risk Communication Research
Verified
Journal Article
Open access
PDF file
MAMartín Morales A
Martín Morales A
JMJaviera Ortega M
Javiera Ortega M
CCCarolina Andrea Campos
Carolina Andrea Campos
The role of inflammation in the pathogenesis of various diseases is of paramount importance, with a significant impact on morbidity and mortality. This underscores the pivotal role of cardiovascular diseases as the leading cause of mortality globally, including in Chile. In this context, the NLRP3 inflammasome, a multiprotein complex of the innate immune system, has been the subject of intense research with regard to its expression and activation in cardiovascular pathologies. The present review addresses the preclinical and clinical scientific evidence, using databases and proceeded to classify the collected molecules according to their mechanism of inhibition of NLRP3 inflammasome activation, exploring their potential therapeutic effect in cardiovascular diseases. In conclusion, it is highlighted that the molecules currently under study show significant improvements in cardiovascular disease symptoms by influencing the priming or activation of the NLRP3 inflammasome.Introduction: . Materials and Methods: . Results: . Discussion: .